Markets
local & international
Asia Pacific
Currencies
Commodities
UK
North America
News
latest news
Latest News
Most Viewed
Business
Currencies
Economy
Markets
Property
Technology
Portfolio
analysis & tools
Portfolios
Alerts
Filters
Reports
Watchlists
Help
Products
products & services
Charting
Data Agent
Data Subscriptions
Historical Data
Investment Game
Pricing
Real Edge
Download
Login
Register
Friday, 29 March 2024
Athenex Inc.
NASDAQ
ATNX
Summary
|
Chart
|
News
|
History
|
More info..
Recent News
More news...
Today Athenex Inc (NASDAQ:ATNX) Reported Decrease in Shorted Shares
08:30 | 19/3/18
Frisco Fastball
The stock of Athenex Inc (NASDAQ:ATNX) registered a decrease of 0.32% in short interest. ATNX's total short interest was 2.02M shares in March as published by FINRA.
more»
Cutting the Cackle: Diving into the Numbers For Athenex, Inc. (NasdaqGS:ATNX)
01:56 | 2/3/18
Danvers Record
In taking a look at some key indicators for Athenex, Inc. (NasdaqGS:ATNX), we note that the current Book to Market value for the firm is at 0.113204.
more»
Creative Planning Sells 162755 Shares of Athenex Inc (ATNX)
16:11 | 27/2/18
StockNewsTimes
Creative Planning cut its stake in shares of Athenex Inc (NASDAQ:ATNX) by 87.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.
more»
Virtus Fund Advisers LLC Buys New Position in Athenex Inc (ATNX)
07:45 | 27/2/18
The Ledger Gazette
Virtus Fund Advisers LLC bought a new position in shares of Athenex Inc (NASDAQ:ATNX) in the 4th quarter, Holdings Channel reports.
more»
Athenex, Inc. to Report Fourth Quarter and Full Year 2017 Earnings Results on ...
01:56 | 27/2/18
GlobeNewswire
Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer.
more»
Jinn Wu Buys 10000 Shares of Athenex Inc (ATNX) Stock
00:29 | 26/2/18
The Ledger Gazette
Athenex Inc (NASDAQ:ATNX) Director Jinn Wu acquired 10,000 shares of the stock in a transaction on Friday, February 9th. The stock was bought at an average price of $13.64 per share, with a total value of $136,400.00.
more»
Athenex, Casilio Cos. win tax breaks for expansion
07:56 | 23/2/18
Buffalo News
Athenex Inc. and real estate developer Casilio Cos. won a package of tax breaks from the Erie County Industrial Development Agency to support an expansion project for the drugmaker's Newstead manufacturing facility.
more»
Athenex Announces Phase II Clinical Study Results for KX2-391 Ointment for the ...
02:07 | 21/2/18
GlobeNewswire
Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer.
more»
Athenex to Present at 2018 RBC Capital Markets Healthcare Conference
01:56 | 17/2/18
GlobeNewswire
Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer.
more»
Athenex Announces Early Completion of Patients Enrollment for Two Phase III ...
01:56 | 15/2/18
GlobeNewswire
Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery and development of next generation drugs for the treatment of cancer.
more»
1
2
3
4
5
6
next»
Global Indices
Code
Last
Change
COMP
10,321
328
3.08%
DJI
29,635
404
1.34%
SP500
3,583
87
2.37%
DAX
12,438
82
0.67%
FTSE
7,488
5
0.07%
NI225
22,420
408
1.86%
TWI
67.27
0.00
0.00%
More news...
No news available...
Currencies
Code
Last
Change
EURUSD
0.9721
0.0055
0.56%
NZDUSD
0.5548
0.0093
1.65%
AUDUSD
0.6194
0.0107
1.70%
NZDAUD
0.8964
0.0010
0.11%